Incidence of glycopeptide heterointermediate Staphylococcus aureus strains in Maltese hospitals

Abstract

The incidence of hetero-intermediate glycopeptide susceptibility among Staphylococcus aureus isolates in Malta, a country with a high incidence of methicillin resistance, was studied by screening 454 non-repetitive S. aureus isolates on teicoplanin-supplemented agar plates, followed by Etests and genotypic studies. All strains were susceptible to vancomycin, but four (0.88%) exhibited teicoplanin MICs of > 12 mg/L. High methicillin-resistant S. aureus endemicity was not an accurate predictor of the emergence of non-susceptibility to glycopeptides. © 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.